There are 2137 resources available
118P - Correlation between PD-L1 expression/TMB and immune cell infiltration: A pan-cancer study
Presenter: Jianping Xiong
Session: E-Poster Display
Resources:
Abstract
119P - A pan-cancer study on difference of homologous recombination deficiency and tumour mutational burden between Chinese and Western patients
Presenter: Naonao Guo
Session: E-Poster Display
Resources:
Abstract
120P - Predictive biomarkers for hyper progression in response to immune checkpoint inhibitors therapy: Analysis of somatic alterations by NGS
Presenter: Ivan Romarico Gonzalez Espinoza
Session: E-Poster Display
Resources:
Abstract
121P - Relationship between different mutation type in JAK1/2/3 and B2M with other biomarkers for immunotherapy in solid tumours
Presenter: Qing Zhang
Session: E-Poster Display
Resources:
Abstract
122P - Serum PDL-1 in colorectal cancer
Presenter: Lyudmila Akhmaltdinova
Session: E-Poster Display
Resources:
Abstract
123P - The prognostic role of lymphocyte count for treatment response in immune checkpoint inhibitor therapy
Presenter: Michael Conroy
Session: E-Poster Display
Resources:
Abstract
124P - Serum parameters as prognostic biomarkers for anti PD-1/PD-L1 therapy in patients with solid tumours: A retrospective data analysis
Presenter: Christoph Minichsdorfer
Session: E-Poster Display
Resources:
Abstract
125P - Association of tumour CD4 positive lymphocytes with prognosis in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor
Presenter: Yan-juan Zhu
Session: E-Poster Display
Resources:
Abstract
126P - Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
Presenter: Neel Nissen
Session: E-Poster Display
Resources:
Abstract
127P - Personalizing treatment in colorectal cancer by monitoring bevacizumab blood levels and ICAM-1 polymorphisms
Presenter: Apostolos Papachristos
Session: E-Poster Display
Resources:
Abstract